Prenatal cannabis: a fetal neuroimaging study of neurodevelopment

Active Project Grant Awarded Last action

Award ID
R01DA054722
Recipient
Awarding agency
Obligated
$5,908,813

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date 89% complete
Originally
Funding
  • $4,708,770.00 Federal
  • $1,200,043.00 Non-federal
Place of performance
Durham, NC 27705, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Current estimates suggest that in north america over 7% of women use cannabis during pregnancy and this use is increasing as legalization becomes more common. Despite the high prevalence of prenatal cannabis exposure, its effects on early brain and behavioral development remain poorly characterized, leaving some with the impression that this exposure is benign or potentially even beneficial (e.g., to treat nausea during pregnancy). Prior neurodevelopmental research on prenatal cannabis effects have had been important limitations including few if any brain/behavioral assessments during first two years of life (a period critical to neurodevelopment), poor characterization of the post-natal environment, and limited assessments of pre- and post-natal maternal mood and anxiety, thus confounding interpretation of prenatal cannabis effects. In our study, we will enroll pregnant women with (N=300) and without a history (N=150) of cannabis use during the first trimester gestation and follow their offspring for the first two years of life with a focus on the neurodevelopment of executive functions. First, we will characterize prenatal cannabis use through pregnancy with self-report measures and biospecimens. Second, we will obtain third trimester fetal MRI scans to character offspring brain structure and function free of post-natal confounds. Third, we will assess offspring cognitive and behavioral development over the first two years of life with parent-report and laboratory-based behavioral assessments. Our design considers critical confounds including parent-infant interactions, pre- and postnatal maternal mood and anxiety symptoms, shared genetic liability, and concomitant drug use during pregnancy. Given the lack of clarity on the safety of cannabis use during pregnancy, findings from this study will have important public health implications by informing prevention messaging and strategies particularly in this ERA of increasing cannabis use.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $240,835 $0
Amendment $339,974 $0
Amendment $585,173 $0
Amendment $571,351 $0
Amendment $571,351 $0
Amendment $577,530 $0
Amendment $577,530 $577,530
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $622,513 $0
Original award $622,513 $622,513
Show all 13

Subawards

Subrecipient Amount Awarded
Universite De Sherbrooke The prime awardee of the proposed research will be Duke University under the direction of Dr.Jonathan Posner, with Dr. Claudia Lugo-Candelas as Multi PI at… $1,374,403
Research Foundation For Mental Hygiene, Inc. The investigative team at RFMH/NYSPI will share responsibility for the overall study design, data management and data quality procedures, interpretation of… $586,580

Quick answers

Who received award R01DA054722?

R01DA054722 was awarded to Duke University by National Institute on Drug Abuse (National Institutes of Health) on September 1, 2021.

How much is award R01DA054722 worth?

$5,908,813 has been obligated on R01DA054722: $4,708,770 in federal funding and $1,200,043 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login